← Evidence map

ArticleOncotarget2024

HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity.

Marcus Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38900671